Potential of MR spectroscopy for assessment of glioma grading

Clinical Neurology and Neurosurgery

Volumn 115, Issue 2, 2013, Pages 146-153

  Bulik, Martin ^a   Jancalek, Radim ^a   Vanicek, Jiri ^a   Skoch, Antonin ^a,b   Mechl, Marek ^c  

^a ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^b INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^c UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

Glioma; Grade; Magnetic resonance spectroscopy; Metabolites

Indexed keywords

CHOLINE; CREATINE; INOSITOL; KI 67 ANTIGEN; LACTIC ACID; LIPID; N ACETYLASPARTIC ACID;

BRAIN BIOPSY; CANCER DIAGNOSIS; CANCER GRADING; CANCER GROWTH; CELL PROLIFERATION; CLINICAL ASSESSMENT; GLIOMA; HISTOPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REVIEW;

ASPARTIC ACID; BRAIN NEOPLASMS; CHOLINE; CREATINE; GLIOMA; HUMANS; INOSITOL; LACTATES; LIPID METABOLISM; MAGNETIC RESONANCE SPECTROSCOPY; NEUROSURGICAL PROCEDURES;

EID: 84872325997     PISSN: 03038467     EISSN: 18726968     Source Type: Journal    
DOI: 10.1016/j.clineuro.2012.11.002     Document Type: Review

References (71)

1. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 CA: A Cancer Journal for Clinicians 60 2010 277 300
2. J.A. Schwartzbaum, J.L. Fisher, K.D. Aldape, and M. Wrensch Epidemiology and molecular pathology of glioma. Nature clinical practice Neurology 2 2006 494 503
3. K.P. Vives, and J.M. Piepmeier Complications and expected outcome of glioma surgery Journal of Neuro-oncology 42 1999 289 302
4. W.A. Hall The safety and efficacy of stereotactic biopsy for intracranial lesions Cancer 82 1998 1749 1755
5. M. Law, S. Yang, H. Wang, J.S. Babb, G. Johnson, and S. Cha Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging AJNR: American Journal of Neuroradiology 24 2003 1989 1998
6. A. Horska, and P.B. Barker Imaging of brain tumors: MR spectroscopy and metabolic imaging Neuroimaging Clinics of North America 20 2010 293 310
7. R.A. Komoroski, C. Heimberg, D. Cardwell, and C.N. Karson Effects of gender and region on proton MRS of normal human brain Magnetic Resonance Imaging 17 1999 427 433
8. B.S. Li, H. Wang, and O. Gonen Metabolite ratios to assumed stable creatine level may confound the quantification of proton brain MR spectroscopy Magnetic Resonance Imaging 21 2003 923 928
9. J. Urenjak, S.R. Williams, D.G. Gadian, and M. Noble Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro Journal of Neurochemistry 59 1992 55 61
10. C.N. Madhavarao, and A.M. Namboodiri NAA synthesis and functional roles J.R. Moffett, S.B. Tieman, D.R. Weinberger, J.T. Coyle, M.A. Namboodiri, N-acetylaspartate: a unique neuronal molecule in the central nervous system 2006 Springer Science + Business Media New York 49 66
11. J.R. Moffett, B. Ross, P. Arun, C.N. Madhavarao, and A.M. Namboodiri N-acetylaspartate in the CNS: from neurodiagnostics to neurobiology Progress in Neurobiology 81 2007 89 131
12. J.H. Neale, T. Bzdega, B. Wroblewska, and N-acetylaspartylglutamate: the most abundant peptide neurotransmitter in the mammalian central nervous system Journal of Neurochemistry 75 2000 443 452
13. P.J. Pouwels, and J. Frahm Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS Magnetic Resonance in Medicine: Official Journal of the Society of Magnetic Resonance in Medicine/Society of Magnetic Resonance in Medicine 39 1998 53 60
14. W. Moller-Hartmann, S. Herminghaus, T. Krings, G. Marquardt, H. Lanfermann, and U. Pilatus Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions Neuroradiology 44 2002 371 381
15. K.E. Warren, J.A. Frank, J.L. Black, R.S. Hill, J.H. Duyn, and A.A. Aikin Proton magnetic resonance spectroscopic imaging in children with recurrent primary brain tumors Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 18 2000 1020 1026
16. G.S. Young Advanced MRI of adult brain tumors Neurologic Clinics 25 2007 947 973
17. D.P. Soares, and M. Law Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications Clinical Radiology 64 2009 12 21
18. R. Hernandez-Alcoceba, L. Saniger, J. Campos, M.C. Nunez, F. Khaless, and M.A. Gallo Choline kinase inhibitors as a novel approach for antiproliferative drug design Oncogene 15 1997 2289 2301
19. Y. Wang, and S.J. Li Differentiation of metabolic concentrations between gray matter and white matter of human brain by in vivo 1H magnetic resonance spectroscopy Magnetic Resonance in Medicine: Official Journal of the Society of Magnetic Resonance in Medicine/Society of Magnetic Resonance in Medicine 39 1998 28 33
20. T. Scholzen, and J. Gerdes The Ki-67 protein: from the known and the unknown Journal of Cellular Physiology 182 2000 311 322
21. H. Shimizu, T. Kumabe, R. Shirane, and T. Yoshimoto Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas AJNR: American Journal of Neuroradiology 21 2000 659 665
22. S.K. Venkatesh, R.K. Gupta, L. Pal, N. Husain, and M. Husain Spectroscopic increase in choline signal is a nonspecific marker for differentiation of infective/inflammatory from neoplastic lesions of the brain Journal of Magnetic Resonance Imaging: JMRI 14 2001 8 15
23. B.C. Bowen Glial neoplasms without elevated choline-creatine ratios AJNR: American Journal of Neuroradiology 24 2003 782 784
24. M. Wyss, and R. Kaddurah-Daouk Creatine and creatinine metabolism Physiological Reviews 80 2000 1107 1213
25. J. Urenjak, S.R. Williams, D.G. Gadian, and M. Noble Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 13 1993 981 989
26. M.K. Lim, C.H. Suh, H.J. Kim, Y.K. Cho, S.H. Choi, and J.H. Kang Systemic lupus erythematosus: brain MR imaging and single-voxel hydrogen 1 MR spectroscopy Radiology 217 2000 43 49
27. E.R. Danielsen, and B. Ross Magnetic resonance spectroscopy diagnosis of neurological diseases 1999 Marcel Dekker New York
28. O.H. Lowry, S.J. Berger, J.G. Carter, M.M. Chi, J.K. Manchester, and J. Knor Diversity of metabolic patterns in human brain tumors: enzymes of energy metabolism and related metabolites and cofactors Journal of Neurochemistry 41 1983 994 1010
29. A. Brand, C. Richter-Landsberg, and D. Leibfritz Multinuclear NMR studies on the energy metabolism of glial and neuronal cells Developmental Neuroscience 15 1993 289 298
30. R.E. Isaacks, A.S. Bender, C.Y. Kim, N.M. Prieto, and M.D. Norenberg Osmotic regulation of myo-inositol uptake in primary astrocyte cultures Neurochemical Research 19 1994 331 338
31. E. Hattingen, P. Raab, K. Franz, F.E. Zanella, H. Lanfermann, and U. Pilatus Myo-inositol: a marker of reactive astrogliosis in glial tumors? NMR in Biomedicine 21 2008 233 241
32. M. Castillo, J.K. Smith, and L. Kwock Correlation of myo-inositol levels and grading of cerebral astrocytomas AJNR: American Journal of Neuroradiology 21 2000 1645 1649
33. J.H. Uhm, N.P. Dooley, J.G. Villemure, and V.W. Yong Glioma invasion in vitro: regulation by matrix metalloprotease-2 and protein kinase C Clinical & Experimental Metastasis 14 1996 421 433
34. G. Fan Comments and controversies: magnetic resonance spectroscopy and gliomas Cancer Imaging: The Official Publication of the International Cancer Imaging Society 6 2006 113 115
35. F. Yamasaki, J. Takaba, M. Ohtaki, N. Abe, Y. Kajiwara, and T. Saito Detection and differentiation of lactate and lipids by single-voxel proton MR spectroscopy Neurosurgical Review 28 2005 267 277
36. P.H. Lai, J.T. Ho, W.L. Chen, S.S. Hsu, J.S. Wang, and H.B. Pan Brain abscess and necrotic brain tumor: discrimination with proton MR spectroscopy and diffusion-weighted imaging AJNR: American Journal of Neuroradiology 23 2002 1369 1377
37. D.N. Louis, H. Ohgaki, O.D. Wiestler, W.K. Cavenee, P.C. Burger, and A. Jouvet The 2007 WHO classification of tumours of the central nervous system Acta Neuropathologica 114 2007 97 109
38. J.H. Hwang, G.F. Egnaczyk, E. Ballard, R.S. Dunn, S.K. Holland, and W.S. Ball Jr. Proton MR spectroscopic characteristics of pediatric pilocytic astrocytomas AJNR: American Journal of Neuroradiology 19 1998 535 540
39. L.N. Sutton, Z. Wang, D. Gusnard, B. Lange, G. Perilongo, and A.R. Bogdan Proton magnetic resonance spectroscopy of pediatric brain tumors Neurosurgery 31 1992 195 202
40. L.M. Harris, N.P. Davies, L. Macpherson, S. Lateef, K. Natarajan, and M.A. Brundler Magnetic resonance spectroscopy in the assessment of pilocytic astrocytomas European Journal of Cancer 44 2008 2640 2647
41. N.P. Davies, M. Wilson, L.M. Harris, K. Natarajan, S. Lateef, and L. Macpherson Identification and characterisation of childhood cerebellar tumours by in vivo proton MRS NMR in Biomedicine 21 2008 908 918
42. L. Porto, M. Kieslich, K. Franz, T. Lehrbecher, S. Vlaho, and U. Pilatus Spectroscopy of untreated pilocytic astrocytomas: do children and adults share some metabolic features in addition to their morphologic similarities? Child's Nervous System: ChNS: Official Journal of the International Society for Pediatric Neurosurgery 26 2010 801 806
43. E. Hattingen, P. Raab, K. Franz, H. Lanfermann, M. Setzer, and R. Gerlach Prognostic value of choline and creatine in WHO grade II gliomas Neuroradiology 50 2008 759 767
44. J. Pallud, L. Capelle, L. Taillandier, D. Fontaine, E. Mandonnet, and R. Guillevin Prognostic significance of imaging contrast enhancement for WHO grade II gliomas Neuro-oncology 11 2009 176 182
45. F. Dhermain, G. Saliou, F. Parker, P. Page, K. Hoang-Xuan, and C. Lacroix Microvascular leakage and contrast enhancement as prognostic factors for recurrence in unfavorable low-grade gliomas Journal of Neuro-oncology 97 2010 81 88
46. E. Shaw, R. Arusell, B. Scheithauer, J. O'Fallon, B. O'Neill, and R. Dinapoli Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20 2002 2267 2276
47. F.B. Furnari, T. Fenton, R.M. Bachoo, A. Mukasa, J.M. Stommel, and A. Stegh Malignant astrocytic glioma: genetics, biology, and paths to treatment Genes & Development 21 2007 2683 2710
48. E. Mandonnet, J.Y. Delattre, M.L. Tanguy, K.R. Swanson, A.F. Carpentier, and H. Duffau Continuous growth of mean tumor diameter in a subset of grade II gliomas Annals of Neurology 53 2003 524 528
49. E. Mandonnet, L. Capelle, and H. Duffau Extension of paralimbic low grade gliomas: toward an anatomical classification based on white matter invasion patterns Journal of Neuro-oncology 78 2006 179 185
50. A. Londono, M. Castillo, D. Armao, L. Kwock, and K. Suzuki Unusual MR spectroscopic imaging pattern of an astrocytoma: lack of elevated choline and high myo-inositol and glycine levels AJNR: American Journal of Neuroradiology 24 2003 942 945
51. E. Saraf-Lavi, B.C. Bowen, P.M. Pattany, E.M. Sklar, J.B. Murdoch, and C.K. Petito Proton MR spectroscopy of gliomatosis cerebri: case report of elevated myoinositol with normal choline levels AJNR: American Journal of Neuroradiology 24 2003 946 951
52. T.R. McKnight, K.R. Lamborn, T.D. Love, M.S. Berger, S. Chang, and W.P. Dillon Correlation of magnetic resonance spectroscopic and growth characteristics within Grades II and III gliomas Journal of Neurosurgery 106 2007 660 666
53. E. Hattingen, O. Delic, K. Franz, U. Pilatus, P. Raab, and H. Lanfermann (1)H MRSI and progression-free survival in patients with WHO grades II and III gliomas Neurological Research 32 2010 593 602
54. F. Giangaspero, P. Chieco, G. Lisignoli, and P.C. Burger Comparison of cytologic composition with microfluorometric DNA analysis of the glioblastoma multiforme and anaplastic astrocytoma Cancer 60 1987 59 65
55. P.C. Burger, F.S. Vogel, S.B. Green, and T.A. Strike Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications Cancer 56 1985 1106 1111
56. A. Giese, R. Bjerkvig, M.E. Berens, and M. Westphal Cost of migration: invasion of malignant gliomas and implications for treatment Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 21 2003 1624 1636
57. E. Goebell, J. Fiehler, X.Q. Ding, S. Paustenbach, S. Nietz, and O. Heese Disarrangement of fiber tracts and decline of neuronal density correlate in glioma patients - a combined diffusion tensor imaging and 1H-MR spectroscopy study AJNR: American Journal of Neuroradiology 27 2006 1426 1431
58. F.A. Howe, S.J. Barton, S.A. Cudlip, M. Stubbs, D.E. Saunders, and M. Murphy Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy Magnetic Resonance in Medicine: Official Journal of the Society of Magnetic Resonance in Medicine/Society of Magnetic Resonance in Medicine 49 2003 223 232
59. C. Remy, N. Fouilhe, I. Barba, E. Sam-Lai, H. Lahrech, and M.G. Cucurella Evidence that mobile lipids detected in rat brain glioma by 1H nuclear magnetic resonance correspond to lipid droplets Cancer Research 57 1997 407 414
60. S.M. Raza, F.F. Lang, B.B. Aggarwal, G.N. Fuller, D.M. Wildrick, and R. Sawaya Necrosis and glioblastoma: a friend or a foe? A review and a hypothesis Neurosurgery 51 2002 2 12 discussion 12-13
61. D.J. Brat, and E.G. Van Meir Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma Laboratory Investigation; A Journal of Technical Methods and Pathology 84 2004 397 405
62. L. Oliver, C. Olivier, F.B. Marhuenda, M. Campone, and F.M. Vallette Hypoxia and the malignant glioma microenvironment: regulation and implications for therapy Current Molecular Pharmacology 2 2009 263 284
63. P. Kleihues Pathology and genetics of tumours of the nervous system P Kleihues, W.K. Cavenee, World Health Organization classification of tumors 2000 IARC Press Lyon
64. S. Saraswathy, F.W. Crawford, K.R. Lamborn, A. Pirzkall, S. Chang, and S. Cha Evaluation of MR markers that predict survival in patients with newly diagnosed GBM prior to adjuvant therapy Journal of Neuro-oncology 91 2009 69 81
65. F.W. Crawford, I.S. Khayal, C. McGue, S. Saraswathy, A. Pirzkall, and S. Cha Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM Journal of Neuro-oncology 91 2009 337 351
66. K. Kallenberg, H.C. Bock, G. Helms, K. Jung, A. Wrede, and J.H. Buhk Untreated glioblastoma multiforme: increased myo-inositol and glutamine levels in the contralateral cerebral hemisphere at proton MR spectroscopy Radiology 253 2009 805 812
67. A. Stadlbauer, S. Gruber, C. Nimsky, R. Fahlbusch, T. Hammen, and R. Buslei Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging Radiology 238 2006 958 969
68. J. Sabatier, V. Gilard, M. Malet-Martino, J.P. Ranjeva, C. Terral, and S. Breil Characterization of choline compounds with in vitro 1H magnetic resonance spectroscopy for the discrimination of primary brain tumors Investigative Radiology 34 1999 230 235
69. L.G. Gonzalez-Bonet Stereotactic biopsy versus spectroscopy in cases of gliomas with a high degree of malignancy. A review of the literature Revista de neurologia 47 2008 310 314
70. M.F. Chernov, Y. Muragaki, T. Ochiai, T. Taira, Y. Ono, and M. Usukura Spectroscopy-supported frame-based image-guided stereotactic biopsy of parenchymal brain lesions: comparative evaluation of diagnostic yield and diagnostic accuracy Clinical Neurology and Neurosurgery 111 2009 527 535
71. O. Ganslandt, A. Stadlbauer, R. Fahlbusch, K. Kamada, R. Buslei, and I. Blumcke Proton magnetic resonance spectroscopic imaging integrated into image-guided surgery: correlation to standard magnetic resonance imaging and tumor cell density Neurosurgery 56 2005 291 298 discussion 291-298